328 related articles for article (PubMed ID: 16722610)
21. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
[TBL] [Abstract][Full Text] [Related]
22. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
[TBL] [Abstract][Full Text] [Related]
23. Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy.
Applefeld MM; Slawson RG; Spicer KM; Singleton RT; Wesley MN; Wiernik PH
Cancer Treat Rep; 1982 Apr; 66(4):1003-13. PubMed ID: 7074628
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
25. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease.
Constine LS; Schwartz RG; Savage DE; King V; Muhs A
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):897-906. PubMed ID: 9369139
[TBL] [Abstract][Full Text] [Related]
26. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease.
Machann W; Beer M; Breunig M; Störk S; Angermann C; Seufert I; Schwab F; Kölbl O; Flentje M; Vordermark D
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1117-23. PubMed ID: 20385449
[TBL] [Abstract][Full Text] [Related]
27. Cardiac dose from tangential breast cancer radiotherapy in the year 2006.
Taylor CW; Povall JM; McGale P; Nisbet A; Dodwell D; Smith JT; Darby SC
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):501-7. PubMed ID: 18374500
[TBL] [Abstract][Full Text] [Related]
28. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
30. [A ventral mantle technic with dorsolateral mediastinal saturation in the radiotherapy of Hodgkin's disease].
Willich N; Bayer M; Krimmel K; Lengsfeld M; Rohloff R; Wendt T
Strahlenther Onkol; 1988 Jul; 164(7):393-401. PubMed ID: 3400047
[TBL] [Abstract][Full Text] [Related]
31. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
King V; Constine LS; Clark D; Schwartz RG; Muhs AG; Henzler M; Hutson A; Rubin P
Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):881-9. PubMed ID: 8960517
[TBL] [Abstract][Full Text] [Related]
33. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
Heidenreich PA; Schnittger I; Strauss HW; Vagelos RH; Lee BK; Mariscal CS; Tate DJ; Horning SJ; Hoppe RT; Hancock SL
J Clin Oncol; 2007 Jan; 25(1):43-9. PubMed ID: 17194904
[TBL] [Abstract][Full Text] [Related]
34. Cardiac complications after radical radiotherapy.
Martinou M; Gaya A
Semin Oncol; 2013 Apr; 40(2):178-85. PubMed ID: 23540743
[TBL] [Abstract][Full Text] [Related]
35. [Radiation-related heart toxicity].
Mège A; Ziouèche A; Pourel N; Chauvet B
Cancer Radiother; 2011 Oct; 15(6-7):495-503. PubMed ID: 21885320
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
[TBL] [Abstract][Full Text] [Related]
37. Quantification of doses to mediastinal lymph nodes in Hodgkin's disease.
Vijayakumar S; Rosenberg I; Brandt T; Spelbring D; Rubin S
Med Dosim; 1992; 17(2):87-94. PubMed ID: 1616597
[TBL] [Abstract][Full Text] [Related]
38. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality.
Lohr F; El-Haddad M; Dobler B; Grau R; Wertz HJ; Kraus-Tiefenbacher U; Steil V; Madyan YA; Wenz F
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):73-80. PubMed ID: 18973977
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
40. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients.
Rademaker J; Schöder H; Ariaratnam NS; Strauss HW; Yahalom J; Steingart R; Oeffinger KC
AJR Am J Roentgenol; 2008 Jul; 191(1):32-7. PubMed ID: 18562721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
